title: Severe skeletal muscle damage following the administration of mesalazine to a patient with ulcerative colitis.
authors: Department of Pediatrics, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. batayann@star.so-net.jp
authors: Nobutada
authors: N
authors: Tabata
authors: Keisuke
authors: K
authors: Sugimoto
authors: Satoshi
authors: S
authors: Ueda
authors: Naoki
authors: N
authors: Sakata
authors: Mitsuru
authors: M
authors: Okada
authors: Toshiharu
authors: T
authors: Miyake
authors: Tohru
authors: T
authors: Shinohara
authors: Makoto
authors: M
authors: Yagi
authors: Takao
authors: T
authors: Satou
authors: Tsukasa
authors: T
authors: Takemura
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects*; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000473:pathology; D009135:Muscular Diseases / Q000139:chemically induced* / Q000473:pathology; D014949:Wounds, Nonpenetrating / Q000139:chemically induced / Q000473:pathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine